Seifert Markus, Tilgen Wolfgang, Reichrath Jörg
Universitäts-Hautklinik, Universitätsklinikum des Saarlandes, Homburg, Germany.
Anticancer Res. 2009 Sep;29(9):3659-67.
In vitro and in vivo studies have demonstrated that the biologically active vitamin D metabolite 1,25-dihydroxyvitamin D (1,25(OH)2D3, calcitriol) suppresses proliferation and induces differentiation in various cell types, including human keratinocytes and melanocytes. Vitamin D is synthesized in the skin from 7-dehydrocholesterol (7-DHC) by the action of UV-B. There are two principal enzymes involved in the formation of circulating 1,25(OH)2D3 from vitamin D, the hepatic microsomal or mitochondrial vitamin D-25-hydroxylase (CYP27A1) and the renal mitochondrial 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1) for vitamin D and 25(OH)D3 (calcidiol), respectively. Extrarenal activity of CYP27B1 has been reported in various cell types including macrophages, keratinocytes, prostate and colon cancer cells. It has been speculated that the extrarenal CYP27B1-mediated local synthesis of 1,25(OH)2D3 represents a key regulator of important cellular functions including growth and differentiation in various cell types and tissues by autocrine or paracrine signalling pathways. The keratinocyte represents the only cell type where the complete enzymatic machinery for the synthesis of 1,25(OH)2D from 7-DHC is present and where the synthesis of 1,25(OH)2D3 from 7-DHC has been shown. In this study, we characterized the pattern of CYP27B1 splice variants in HaCaT keratinocytes in vitro. Applying nested touch-down PCR, the full length CYP27B1 gene product and several additional CYP27B1 splice variants were detected. The pattern of CYP27B1 splice variants varied depending on the cell density, the calcium concentration of the medium ([Ca2+]o), and UV-B treatment. It can be speculated whether increased expression of CYP27B1 splice variants that lack enzymatic activity (Hyd-V3/V5) may result in a reduction of enzymatic activity and in reduced synthesis of 1,25(OH)2D3. Further study of the impact of CYP27B1 splice variants on the vitamin D pathway in keratinocytes and other cell types is warranted.
体外和体内研究表明,具有生物活性的维生素D代谢产物1,25 - 二羟基维生素D(1,25(OH)2D3,骨化三醇)可抑制多种细胞类型(包括人角质形成细胞和黑素细胞)的增殖并诱导其分化。维生素D由皮肤中的7 - 脱氢胆固醇(7 - DHC)经UV - B作用合成。从维生素D形成循环中的1,25(OH)2D3涉及两种主要酶,即肝脏微粒体或线粒体维生素D - 25 - 羟化酶(CYP27A1)和肾脏线粒体25 - 羟基维生素D - 1α - 羟化酶(CYP27B1),分别作用于维生素D和25(OH)D3(骨化二醇)。已报道CYP27B1在包括巨噬细胞、角质形成细胞、前列腺癌细胞和结肠癌细胞在内的多种细胞类型中具有肾外活性。据推测,肾外CYP27B1介导的1,25(OH)2D3局部合成通过自分泌或旁分泌信号通路代表了包括多种细胞类型和组织中生长与分化在内的重要细胞功能的关键调节因子。角质形成细胞是唯一存在从7 - DHC合成1,25(OH)2D完整酶系且已显示能从7 - DHC合成1,25(OH)2D3的细胞类型。在本研究中,我们对体外培养的HaCaT角质形成细胞中CYP27B1剪接变体的模式进行了表征。应用巢式降落PCR,检测到全长CYP27B1基因产物以及几种额外的CYP27B1剪接变体。CYP27B1剪接变体的模式因细胞密度、培养基钙浓度([Ca2+]o)和UV - B处理而有所不同。可以推测,缺乏酶活性的CYP27B1剪接变体(Hyd - V3/V5)表达增加是否可能导致酶活性降低以及1,25(OH)2D3合成减少。有必要进一步研究CYP27B1剪接变体对角质形成细胞和其他细胞类型中维生素D途径的影响。